Article info
PDFNeurological rarities
Glial fibrillary acidic protein antibody-positive meningoencephalomyelitis
- Correspondence to Dr Angeliki Zarkali, East Kent Neurology Unit, East Kent University Hospitals NHS Foundation Trust, Margate CT9 4AN, UK; angeliki.zarkali{at}nhs.net
Citation
Glial fibrillary acidic protein antibody-positive meningoencephalomyelitis
Publication history
- Accepted January 14, 2018
- First published February 9, 2018.
Online issue publication
July 13, 2018
Article Versions
- Previous version (12 July 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD
- Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
- Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease
- CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica
- Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders
- Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis
- Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies
- Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
- Neuromyelitis optica spectrum disorder as a paraneoplastic syndrome: a rare and challenging diagnosis
- Overlapping CNS inflammatory diseases: differentiating features of NMO and MS